Related US Application Data 5,163,441 A 1 1/1992 Monthony et al.(63) Continuation-in-part
of application No. 12/916,263,(Continued) filed on Oct. 29, 2010, and a continuation-in-part …

Addition of a bacterial ADP-ribosylating exotoxin (bARE) to a formulation (eg, immunogen or
vaccine) or a System (eg, patch or kit) for immunization enhances the immune response in a …

4,529,702 A 7/1985 Bryan(57) ABSTRACT 4,554,101 A 11/1985 HPPP Disclosed are
compositions for isolating populations of 4559231 A 12/1985 B18rre. etal' nucleic acids from …

A61K47/50—Medicinal preparations characterised by the non-active ingredients used, eg
carriers or inert additives; Targeting or modifying agents chemically bound to the active …

CI2O I/68(2006.01) CA Office action for PCT/US08/78499, dated Mar. 29, 2012. CI2O
1/70(2006.01) CA Office action for PCT/US2007/078025, dated Jan. 4, 2011. CI2N …

Disclosed are oligonucleotide amplification primers and detection probes specific for the
amplification and detection of pathogenic organisms, including for example, specific …

(72) Inventors: Gerald W. Fischer, Bethesda, MD 4,601,903. A 7, 1986 Frasch (US); Luke T.
Daum, San Antonio, TX 4,608,251 A 8, 1986 Mia US) 4,634,664 A 1/1987 Oestberg …

Vaccines against prion disease eliciting a humoral immune response when administered
mucosally are described. The vaccines comprise a prion protein, a prion protein fragment, or …

The invention is directed to compositions and methods for rapidly and efficiently extracting
nucleic acids and/or targeted nucleic acids sequences from biological samples. The …

Disclosed are compositions for isolating populations of nucleic acids from biological,
forensic, and environmental samples. Also disclosed are methods for using these …